Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat - Wikidata - wikimedia - TriplyDB

Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat

Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat

http://www.wikidata.org/entity/Q30975439

about

Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa Novel Strategies for the Improvement of Stem Cells' Transplantation in Degenerative Retinal Diseases Update on Clinical Trials in Dry Age-related Macular Degeneration Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease Current therapeutic developments in atrophic age-related macular degeneration Patient-Specific iPSC-Derived RPE for Modeling of Retinal Diseases Advancements in stem cells treatment of skeletal muscle wasting Stem cells in retinal regeneration: past, present and future Stem cell treatment of degenerative eye disease Using human induced pluripotent stem cells to treat retinal disease Promises of stem cell therapy for retinal degenerative diseases Engrafted human induced pluripotent stem cell-derived anterior specified neural progenitors protect the rat crushed optic nerve Transplantation of rat embryonic stem cell-derived retinal progenitor cells preserves the retinal structure and function in rat retinal degeneration.Efficacy and Safety of Human Retinal Progenitor Cells Localized RPE Removal with a Novel Instrument Aided by Viscoelastics in Rabbits Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium Induced Pluripotent Stem Cells: Development in the Ophthalmologic Field Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)Development of gene and stem cell therapy for ocular neurodegeneration Retinal pigment epithelium transplantation: concepts, challenges, and future prospects Stem cell-based therapies for age-related macular degeneration: current status and prospects Developing rods transplanted into the degenerating retina of Crx-knockout mice exhibit neural activity similar to native photoreceptors Long-Term Efficacy of GMP Grade Xeno-Free hESC-Derived RPE Cells Following Transplantation.Human iPSC-Derived Neural Progenitors Preserve Vision in an AMD-Like Model Understanding photoreceptor outer segment phagocytosis: use and utility of RPE cells in culture.Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells.Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival.Dry age-related macular degeneration: A currently unmet clinical need.MicroRNA expression profiles of human iPS cells, retinal pigment epithelium derived from iPS, and fetal retinal pigment epithelium.Generating retinal neurons by reprogramming retinal pigment epithelial cells.Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells.Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium.Induced pluripotent stem cells without c-Myc ameliorate retinal oxidative damage via paracrine effects and reduced oxidative stress in rats.The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells.Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells.Stem cell therapies for age-related macular degeneration: the past, present, and future.Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate.Performing subretinal injections in rodents to deliver retinal pigment epithelium cells in suspension Deriving retinal pigment epithelium (RPE) from induced pluripotent stem (iPS) cells by different sizes of embryoid bodies

P2860

Q24600170-73DF98DF-9AF8-4F11-87EA-1D3E128B85DC Q26746982-1A4FF85D-9334-4C85-A1E1-D4983C55A667 Q26767098-2674E4A0-EB3D-4788-8DE1-5B6B58F66409 Q26774786-7803AAE9-8650-414C-9E3B-7DBAFF7E8FBA Q26778247-60540677-562D-4FA3-8424-EE7E5100AB81 Q26799586-2E853E17-961E-4006-9511-439945B0C964 Q26822437-DC570374-ED54-41A5-B406-49A8AD07BF1E Q26828014-1FEDA35F-BE60-4F09-9ED7-0B5A98973703 Q26865154-9EBCEB4C-59AB-4792-8BEB-63C08EF5FEC0 Q27015087-4A6A4163-DBCC-4D63-B8B5-8CD52A8C8872 Q27015655-D37AE969-4FBC-4265-AFF0-9A360573FED1 Q27309127-C93FC2D5-D75F-4DCB-A36E-42EE732ADFEE Q27322474-8C6CBC0C-E14B-45DF-A4C0-115004FB0E7A Q27334445-CDA7D2DF-020F-4C98-A79F-871880278D55 Q27334478-E4AC325B-2B15-4127-A2CE-7829AE8056C9 Q27694625-E559373B-8CF1-4BC1-AF77-5937AC253507 Q28073316-C369EE83-A7BF-42A8-955D-2D2E31AA67A5 Q28077285-CBAB1C94-0B77-4F76-92C6-C474EF157BDA Q28081549-D3D8C598-06E8-4962-816F-85B4A051145A Q28083235-4521D2FF-0E7A-4131-A106-26E8A1D8B9D3 Q28083236-4351C6CB-0A7D-4990-A673-B55E362D1560 Q30661642-5DCD9BC6-3215-4FA1-A6D9-C1140C407471 Q33803526-F3F1BD3A-3C16-4D5F-AB0B-164B99163C38 Q33816116-A277B734-18EC-47A7-84AE-4F8E00F26150 Q34090518-D80E3645-7DE5-41B2-B108-7156C063ADA6 Q34175757-4DA2CBE9-AFA1-4766-BBE1-377D59867BFC Q34278003-9F4264D5-BFF8-4AED-AC10-4CD26FD2250D Q34281455-F6756C65-9657-4E32-B1C8-5093E4A84ACA Q34378033-81BDE451-1442-440C-8BD8-66F04066D77A Q34380217-292C6805-4FC3-4CAF-9932-709D3C319219 Q34412135-5E0CE632-714D-4535-99EB-B018E244E4AB Q34442266-D760CC5F-4693-4A33-A42B-7E99A49A522E Q34445030-532FA5AD-A055-4470-801A-34EA6BDBCFCA Q34454918-CC9EEDA7-EA5C-4F57-92CD-A823874D7311 Q34494259-23A51ACA-86FF-49C4-8EAC-061FEF3BC917 Q34604767-154CB7B6-F7D1-4A2F-BF58-C3263F58365B Q34982149-09EB8343-5C87-4781-8791-149314A2DD7E Q35001372-6D196827-067B-4AEF-A44B-FA0204FADE83 Q35161969-E38FE62F-4258-4AFE-9B73-CB3582E13572 Q35162146-86B55033-AD9E-4050-9807-BB0DAC33737A

P2860

Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat

http://www.wikidata.org/entity/Q30975439

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Protective effects of human iP ...... in the retinal dystrophic rat

@ast

Protective effects of human iP ...... in the retinal dystrophic rat

@en

type

label

Protective effects of human iP ...... in the retinal dystrophic rat

@ast

Protective effects of human iP ...... in the retinal dystrophic rat

@en

prefLabel

Protective effects of human iP ...... in the retinal dystrophic rat

@ast

Protective effects of human iP ...... in the retinal dystrophic rat

@en

P1433

Q30975439-0B3CE999-663A-42FC-A664-33A52CFC07F3

P1476

Q30975439-A82C1191-F59A-4743-AEF6-5E7C6C9E467E

P2093

Q30975439-13296F90-87F8-4FF6-B8CA-E7332BDFB270

Q30975439-2D095B54-4A9E-4B8E-AAA8-1DDF8F2FB7A9

Q30975439-3844CFFB-69EB-4221-9FFE-880905C76039

Q30975439-3FE8E23F-81A0-4C10-8C9D-E1379FC9C4A0

Q30975439-4C4707AD-4D4E-4903-AB2C-F562BC0F889C

Q30975439-6051C71A-86F8-45AC-A3C6-B98B906A462E

Q30975439-74D0EC9C-75B8-40C6-8F47-C05733C977FE

Q30975439-84BB40E0-71AF-4B30-9623-26D2CD0D8E2A

Q30975439-87403354-A092-466B-A002-A49ADF0353B1

Q30975439-8BFB84F8-9011-4585-8558-443509FEAD86

P2860

Q30975439-0362B688-CCFC-454D-A949-ECB24F9ECC1D

Q30975439-04EBCBD8-0020-4782-A6E8-0E92F95DF64E

Q30975439-12401AA3-70CB-4FFD-AEEE-DEB17BC25AC5

Q30975439-140A93AD-258D-4379-A246-2CA07D37EBD8

Q30975439-147FDF06-372F-4DDF-B6B4-86303893A988

Q30975439-14D44DE8-941C-4754-853B-573FCCAE2B93

Q30975439-1714E658-3E9F-4D8A-A92E-A4138DEEAF15

Q30975439-1BC4E842-1697-4351-9685-7E65AE29A3FE

Q30975439-1D71C1D1-B16B-4447-B1E2-18F1218441BD

Q30975439-1F9348C8-8350-451D-87A3-FA081B2BD98A

P304

Q30975439-E7BB7F5E-EFA7-4171-A403-F22EDB52ABC7

P31

Q30975439-A7EE2683-F1C8-4DFE-9B77-B7A8E4848148

P356

Q30975439-C211FFC5-04B6-4B60-9CA6-3E789613B852

P407

Q30975439-D3E27B21-A133-4BBB-8422-4571BE2E516B

P433

Q30975439-574745FF-AB1D-48DC-8418-779B3EA3D870

P478

Q30975439-216CAF05-4A3F-4D97-B0DA-CEEE282084AD

P577

Q30975439-D7BCCBE2-7B89-40AE-8009-0C928A1F4145

P5875

Q30975439-D48E2E32-3D75-4DA2-B22E-BFC7F5C2ADCF

P698

Q30975439-60DB92FD-8965-4140-8B89-862A818A0E23

P932

Q30975439-94A8F390-6EF4-416D-96F8-774FE85069A2

P356

JOURNAL.PONE.0008152

P1433

P1476

Protective effects of human iP ...... in the retinal dystrophic rat

@en

P2093

Ahmad Ahmado

http://www.w3.org/2001/XMLSchema#string

Amanda-Jayne Carr

http://www.w3.org/2001/XMLSchema#string

Anthony A Vugler

http://www.w3.org/2001/XMLSchema#string

Carlos Gias

http://www.w3.org/2001/XMLSchema#string

David E Buchholz

http://www.w3.org/2001/XMLSchema#string

Dennis O Clegg

http://www.w3.org/2001/XMLSchema#string

Jean M Lawrence

http://www.w3.org/2001/XMLSchema#string

Li Li Chen

http://www.w3.org/2001/XMLSchema#string

Lincoln V Johnson

http://www.w3.org/2001/XMLSchema#string

Lyndon da Cruz

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

Induced pluripotent stem cell lines derived from human somatic cells

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat

Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration

Human induced pluripotent stem cells free of vector and transgene sequences

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

P304

e8152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0008152

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40484459

http://www.w3.org/2001/XMLSchema#string

P698

19997644

http://www.w3.org/2001/XMLSchema#string

P932

2780911

http://www.w3.org/2001/XMLSchema#string